Key Metrics
CiteScore 

2.6
Impact Factor 

< 5
SJR 

Q3Immunology

SNIP 

0.58
Recommended pre-submission checks
Powered by 

Topics Covered on Immunity, inflammation and disease
Immunity, inflammation and disease Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Article-by-article |
| Article Processing Charges | EUR 2550 | GBP 2100 | USD 3267 |
| Publication Time | 8 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Article-by-article |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Immunity, inflammation and disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Immunity, inflammation and disease
The Unprecedented Influenza Epidemic of 2024/2025: Overshadowing the COVID‐19 Winter Wave and Exploring Viral Interference
- 20 Nov 2025
- Immunity, Inflammation and Disease
The Imbalanced Patterns and Clinical Significance of Cytokines in Acute Myeloid Leukemia Microenvironment
- 10 Nov 2025
- Immunity, Inflammation and Disease
Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases
- 10 Nov 2025
- Immunity, Inflammation and Disease
Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
- 1 Nov 2025
- Immunity, Inflammation and Disease
Tacrolimus Trough Concentration‐Escalating Bipartite Therapy (Glucocorticoids Combined With Tacrolimus) for Refractory MDA5 Antibody‐Positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Pneumonia
- 1 Nov 2025
- Immunity, Inflammation and Disease
Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
- 1 Nov 2025
- Immunity, Inflammation and Disease
The Unprecedented Influenza Epidemic of 2024/2025: Overshadowing the COVID‐19 Winter Wave and Exploring Viral Interference
- 20 Nov 2025
- Immunity, Inflammation and Disease
The Imbalanced Patterns and Clinical Significance of Cytokines in Acute Myeloid Leukemia Microenvironment
- 10 Nov 2025
- Immunity, Inflammation and Disease
Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases
- 10 Nov 2025
- Immunity, Inflammation and Disease
Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
- 1 Nov 2025
- Immunity, Inflammation and Disease
Tacrolimus Trough Concentration‐Escalating Bipartite Therapy (Glucocorticoids Combined With Tacrolimus) for Refractory MDA5 Antibody‐Positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Pneumonia
- 1 Nov 2025
- Immunity, Inflammation and Disease
Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
- 1 Nov 2025
- Immunity, Inflammation and Disease